IDIman Dajani

Iman Dajani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Iman Dajani has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Multimodal neuroimaging in Alzheimer's disease: A practical, case-illustrated review of quantitative MRI and molecular PET

    by Iman Dajani, Nila Alsheik, Ali Chaari

    Alzheimer's disease (AD) accounts for 60–70% of dementia cases worldwide. Current diagnostic pathways rely on structural magnetic resonance imaging (MRI) to exclude secondary causes, amyloid positron emission tomography (PET) to confirm pathology, and tau PET for disease staging. However, these approaches are limited by subjectivity, cost, accessibility, and variability in interpretation. Quantitative imaging tools such as volumetric MRI and NeuroQuant offer reproducible metrics that may enhance diagnostic precision and standardization. This review synthesizes literature published between 2000 and 2026 evaluating structural MRI, quantitative volumetric MRI, amyloid PET, tau PET, FDG PET, and emerging adjunctive imaging techniques, supplemented by illustrative clinical cases demonstrating multimodal integration in practice. Particular emphasis is placed on the role of NeuroQuant in standardized atrophy quantification and its integration with molecular imaging modalities. Volumetric MRI enhances PET-based diagnosis and staging by contextualizing amyloid and tau pathology within patterns of selective neurodegeneration. Quantitative metrics correlate with cognitive decline and disease progression. Multimodal imaging strategies improve diagnostic specificity, longitudinal monitoring, and phenotypic stratification across the AD. Multimodal imaging provides a comprehensive framework for AD management. Quantitative MRI using NeuroQuant bridges structural and molecular domains, supporting standardized assessment and integration with emerging precision diagnostic approaches.

  • Open Access

    The Effect of Microbiome‐Modulating Therapeutics on Anthropometric and Hemodynamic Biomarkers in Metabolic Syndrome: A Systematic Review, Meta‐Analysis, and Meta‐Regression of Clinical Trials

    by Pradipta Paul, Iman Dajani, Ridhima Kaul, Ali Chaari

    Background: Metabolic syndrome (MetS) is a prevalent cardiometabolic disorder characterized by central obesity, insulin resistance, dyslipidemia, and hypertension. Microbiome‐targeted therapies with probiotics, prebiotics, and synbiotics may improve outcomes by modulating metabolism, inflammation, and blood pressure. Methods: We conducted a systematic review and meta‐analysis of randomized controlled trials (RCTs) in adults with MetS. Searches through April 2023 identified eligible RCTs, yielding 19 studies and 21 independent comparisons. Pooled mean differences (MDs) with 95% confidence intervals (CIs) were calculated using a random effects model. Subgroup analyses and meta‐regressions examined moderators and heterogeneity. Results: A total of 19 studies comprising 21 trial comparisons were included. Microbiome‐modulating interventions were associated with modest reductions in waist circumference and body weight (BW), indicating improvements in central adiposity. In contrast, effects on body mass index (BMI) were limited, and no meaningful changes were observed in systolic or diastolic blood pressure (DBP). Subgroup and meta‐regression analyses suggested that higher microbial dose, longer intervention duration, and greater baseline adiposity were associated with more pronounced anthropometric responses. Moderate heterogeneity was observed across several outcomes. Conclusions: Microbiome‐targeted therapies reduced waist circumference (WC) and BW in MetS but had no effect on BMI, systolic blood pressure (SBP), or DBP. These safe interventions may complement lifestyle strategies. Larger, standardized trials with microbiome profiling are needed to refine therapeutic use. These findings support a potential adjunctive role for microbiome‐targeted therapies in MetS, particularly for central adiposity, though standardized, longer duration trials with microbiome profiling are needed to clarify clinical utility.

  • Open Access

    Dementia in the Middle East and North Africa: an integrative narrative review of epidemiology, risk structure, and health system implications

    by Iman Dajani, Anns Mahboob, Shahad Sabaawi Ibrahim, Raghad Sabawi Ibrahim, Mohsen Sedighi, Zahra Shirzadi, Simin Mahinrad, Serena Sabatini, Ahmad R Khatoonabadi, Matthew Prina, et al.

    Dementia prevalence in the Middle East and North Africa (MENA) is projected to rise exponentially, with estimates suggesting increases of 367% by 2050. This region faces distinctive challenges, including rapid demographic transition, high rates of modifiable risk factors, and fragmented health systems. This paper examines region-specific risk factors and pooled prevalence rates of dementia across the MENA region. We conducted a narrative review of dementia risk factors in the MENA region, including analysis of population-attributable risk (PAR) estimates and pooled estimates of dementia prevalence among adults aged 50 years and older. Dementia prevalence was estimated at 1.84% among individuals aged 50 years and older, increasing to 3.81% among those aged 60 years and older, with substantial variability across countries. Smoking (>30%), physical inactivity ( ~ 50%), and high burdens of diabetes, hypertension, and obesity were consistently associated with increased dementia risk. Additional region-specific drivers include nutritional transitions, gut dysbiosis, consanguinity, and environmental risk factors such as air pollution and climate-related heat stress. Critical barriers to prevention and care include limited research infrastructure, low health literacy, stigma, and inequitable health care access. Dementia prevalence in MENA is rising rapidly, driven by demographic change and high exposure to modifiable risk factors that are relatively region-specific in terms of their contribution. Strengthening prevention, early detection, and equitable access to care should be regional health priorities.

  • Open Access

    The Role of Artificial Intelligence in the Characterization and Outcome Prediction of Prostate Cancer: A Systematic Review

    by Shahd Aljoudi, Aasiya Khan, Iman Dajani, Minatullah Al-Ani, Michael Mina, Dounia Baroudi, Sama Al-Saffar, Souha Aouadi, Tarraf Torfeh, Rabih Hammoud, et al.

    Background/Objectives: Prostate cancer (PCa) is the second most commonly diagnosed cancer in men globally. Radiation oncologists often find PCa tumor characterization and outcome prediction challenging. Therefore, the potential for artificial intelligence (AI) implementation in radiation oncology has increased in recent years. This systematic review aims to evaluate the efficacy of AI algorithms in characterizing PCa tumors and predicting post-therapy outcomes. Methods: A total of 2055 studies were identified through a comprehensive search across PubMed and Scopus, then exported to Covidence. Inclusion criteria focused on prospective and retrospective cohort studies as well as randomized clinical trials (RCTs) published between 2015 and 2024 that explored the implementation of AI in tumor characterization and outcome prediction of PCa. Two independent reviewers evaluated each paper, and evaluation metrics such as specificity, sensitivity, accuracy, and area under the curve (AUC) were analyzed. The Risk of Bias in Non-randomized Studies of Interventions, Version 2 (ROBINS-I V2) tool was used to assess the risk of bias (ROB). Results: Across the 19 studies analyzed, there was no significant difference in model performance between machine learning (ML) and deep learning (DL) models. AI models using multi-input strategies (e.g., radiomics with clinical markers) generally performed better than single-input models. Of the imaging modalities used for radiomic feature extraction, multiparametric MRI (mpMRI)-trained AI models consistently achieved the highest performance. Conclusions: AI displays considerable potential for integration into clinical workflows for PCa management. However, further studies utilizing larger datasets and external cohorts independent of the sample population are needed to validate clinical utility and improve model transparency for reliable implementation.


  • Open Access

    Immersive virtual reality for teaching hemoglobin structure in preclinical medical biochemistry education: a mixed-methods study of student self-reported perceptions

    by Iman Dajani, Maria Christina Esteban, Ali Chaari

    Background: Understanding protein structure is foundational to preclinical medical education and underpins later learning in hematology, physiology, and pharmacology. However, many biochemical concepts, particularly those involving three-dimensional molecular architecture, are difficult for students to conceptualize using traditional two-dimensional instructional tools. Immersive virtual reality (VR) enables interactive, stereoscopic visualization of biomolecules and may support spatial understanding of complex protein structures. This study aimed to evaluate undergraduate preclinical medical students’ self-reported perceptions of learning, spatial understanding, and engagement following a VR-based instructional session focused on hemoglobin structure. Methods & data analysis: In this mixed-methods study, a retrospective within-session pre/post evaluation was embedded within a preclinical medical biochemistry course at Weill Cornell Medicine-Qatar. Students used the Nanome platform on standalone VR headsets to explore hemoglobin’s quaternary structure, heme coordination, and conformational transitions. Quantitative outcomes were assessed using three 10-point Likert-scale items administered before and after the session. Qualitative data were collected through open-ended survey questions and analyzed thematically. Results: Fifty-four students participated. Following the VR session, a larger proportion of students selected the highest rating categories for perceived usefulness of VR (63%), spatial understanding of hemoglobin (66.7%), and overall structural understanding (70.5%). Overall responses reflected consistently positive self-reported perceptions of learning and visualization. Mild discomfort related to headset use was reported by a minority of participants (35 none, 13 transient, 6 persistent). Qualitative feedback highlighted clearer subunit differentiation, improved visualization of the heme environment, and collaborative discussion. Conclusions: VR-based molecular visualization was associated with consistently positive student-reported perceptions of spatial understanding and engagement in preclinical biochemistry education. These findings suggest that immersive VR may serve as a feasible adjunct to conventional instructional methods for teaching spatially complex molecular concepts.